RenovoRx RNXT
NASDAQ RNXT
$1.57 +0.01 (+0.64%)
As of: Oct 1, 2026 · 1:51 PM EDT

RenovoRx (RNXT) Accumulated Depreciation (2025)

Updated

RenovoRx (RNXT) reported Accumulated Depreciation of $2,000 for Q4 2025, unchanged from the prior quarter.

Analysis

RenovoRx (RNXT) Accumulated Depreciation (2025) Analysis & Trends

Dating back to Q1 2025, RenovoRx's Accumulated Depreciation record includes 4 quarters.

  • Per Business Quant data, the three quarters before Q4 2025 came in at $2,000 (Q3 2025), $2,000 (Q2 2025) and $1,000 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 RenovoRx 70.39 Mn 70.39 Mn 766,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2,000.00
Sep 30, 2025 2,000.00
Jun 30, 2025 2,000.00
Mar 31, 2025 1,000.00
API Access

RenovoRx Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=RNXT&period=max&api_key=YOUR_API_KEY